Increased serological cancer-associated biomarker levels at large bowel endoscopy and risk of subsequent primary cancer^†

References

• De Cecco CN, Ciolina M, Annibale B, et al. Prevalence and distribution of colonic diverticula assessed with CT colonography (CTC). Eur Radiol. 2015; [Epub ahead of print]. DOI: 10.1007/s00330-015-3866-1.
   Web of Science ®Google Scholar
• Nagata N, Niikura R, Aoki T, et al. Association between colonic diverticulosis and bowel symptoms: a case-control study of 1,629 Asian patients. J Gastroenterol Hepatol. 2015;30:1252–1259.
   PubMed Web of Science ®Google Scholar
• Peery AF, Sandler RS. Diverticular disease: reconsidering conventional wisdom. Perspect Clin Gastroenterol Hepatol. 2013;11:1532–1537.
   PubMed Web of Science ®Google Scholar
• Kieff BJ, Eckart GJ, Imperiale TF. Is diverticulosis associated with colorectal neoplasia? A cross-sectional colonoscopic study. Am J Gastroenterol. 2004;99:2007–2011.
   PubMed Web of Science ®Google Scholar
• Rafferty J, Shellito P, Hyman NH, et al. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum. 2006;49:939–944.
   PubMed Web of Science ®Google Scholar
• Granlund J, Svensson T, Granath F, et al. Diverticular disease and the risk of colon cancer – a population-based case-control study. Aliment Pharmacol Ther. 2011;34:675–681.
   PubMed Web of Science ®Google Scholar
• Westwood DA, Eglinton TW, Frizelle FA. Routine colonoscopy following acute uncomplicated diverticulitis. Br J Surg. 2011;98:1630–1634.
   PubMed Web of Science ®Google Scholar
• Huang WY, Lin CC, Jen YM, et al. Association between colonic diverticular disease and colorectal cancer: a nationwide population-based study. Clin Gastroenterol Hepatol. 2014;12:1288–1294.
   PubMed Web of Science ®Google Scholar
• Alexandersson BT, Hreinsson JP, Stefansson T, et al. The risk of colorectal cancer after an attack of uncomplicated diverticulitis. Scand J Gastroenterol. 2014;49:576–580.
   PubMed Web of Science ®Google Scholar
• Vaidya KK, Floch MH. Diverticular disease: paradigm shifts in pathogenesis and treatment. Curr Treat Options Gastroenterol. 2015;13:143–155.
   PubMedGoogle Scholar
• Kring TS, Piper TB, Jørgensen LN, et al. Blood based biomarkers at large bowel endoscopy and prediction of future malignancies. Biomarkers Cancer. 2015;7:57–61.
   PubMedGoogle Scholar
• Nielsen HJ, Brünner N, Jørgensen LN, et al. Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4,509 high-risk individuals. Scand J Gastroenterol. 2011;46:60–69.
   PubMed Web of Science ®Google Scholar
• Allin KH, Bojesen SE, Johansen JS, et al. Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population. Br J Cancer. 2012;106:199–205.
   PubMed Web of Science ®Google Scholar
• Johansen JS, Christensen IJ, Jørgensen LN, et al. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev Biomark. 2015;24:621–626.
   PubMed Web of Science ®Google Scholar
• Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–1154.
   Web of Science ®Google Scholar
• Christensen IJ, Brünner N, Stieber P, et al. Plasma TIMP-1 and CEA as markers for detection of primary colorectal cancer: a prospective validation study of 1965 individuals. Anticancer Res. 2015;35:4935–4941.
   PubMed Web of Science ®Google Scholar
• Allin KH, Nordestgaard BG, Zacho J, et al. C-reactive protein and the risk of cancer: a Mendelian randomization study. study. J Natl Cancer Inst. 2010;102:202–206.
   PubMedGoogle Scholar
• Tsilidis KK, Branchini C, Guellar E, et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer. 2008;123:1133–1140.
   PubMed Web of Science ®Google Scholar
• Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48:155–170.
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Kopetz S, Brenner DE. Blood-based tests for colorectal cancer screening: do they threaten the survival of the FIT test? Dig Dis Sci. 2015;60:664–671.
   PubMed Web of Science ®Google Scholar
• Thusison T, Christensen IJ, Lund IK, et al. Circulating intact and cleaved forms of urokinase-type plasminogen activator receptor: biological variation, reference intervals and clinical useful cut-points. Clin Chim Acta. 2015;439:84–90.
   PubMed Web of Science ®Google Scholar
• Reinert T, Schøler LV, Thomsen R, et al. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut. 2015;pii:gutjnl-2014-308859.
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Dharuman Y, Standop J, et al. Novel serum nucleosomics biomarkers for the detection of colorectal cancer. Anticancer Res. 2014;34:2357–2362.
   PubMed Web of Science ®Google Scholar
• Clancy C, Joyce MR, Kerin MJ. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Cancer Biomark. 2015;15:103–113.
   PubMed Web of Science ®Google Scholar
• Bro R, Nielsen HJ, Savarani F, et al. Data fusion in metabolomic cancer diagnostics. Metabolomics. 2013;9:3–8.
   PubMed Web of Science ®Google Scholar